Stay updated with breaking news from Shanton Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a groundbreaking treatment for refractory and tophaceous gout patients, today...
SAP-001 is an oral once-a-day investigational gout product with Best-in-Class potential for acute and chronic use in uncontrolled patients BRIDGEWATER, N.J., Jan. 9, 2023 /PRNewswire/ --
- SAP-001 is an oral once-a-day investigational Gout product with Best-in-Class potential for acute and chronic use in uncontrolled patients BRIDGEWATER, ...
/PRNewswire/ -- DelveInsight's Chronic Gout Market Insights report includes a comprehensive understanding of current treatment practices, Chronic Gout emerging...